Maria Greenwald

Desert Medical Imaging — United States

Medicine · Health Sciences

35h-index9.5kcitations100works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Rheumatoid Arthritis Research and Therapies(50), Chronic Lymphocytic Leukemia Research(23), Bone health and osteoporosis research(19), Autoimmune and Inflammatory Disorders Research(16), Lymphoma Diagnosis and Treatment(12)

Publications99 total

Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study
RMD Open·2025· 4 citedOpen Access
Assessment of Major Adverse Cardiovascular Events and Thrombotic Risk for Patients with Rheumatic Disease
Medical Research Archives·2025Open Access
A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment
Lara D. Veeken·2024· 2 citedOpen Access
P123 Safety and efficacy of filgotinib, an update from the DARWIN 3 phase 2 long-term extension with a maximum of 8.2 years of exposure
Lara D. Veeken·2024Open Access
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk‐Enriched Rheumatoid Arthritis Patients
Arthritis & Rheumatology·2024· 23 citedOpen Access
Predicting Thrombotic Events in Rheumatoid Arthritis by Using Bleeding Time: Look at the Platelet
Medical Research Archives·2024Open Access
Hearing Loss As A Surrogate Marker For Early Atherosclerosis in A High-Risk Population: A Prospective Study
The American Journal of Cardiology·2023· 3 citedOpen Access
POS0829 SAFETY AND EFFICACY OF FILGOTINIB: AN UPDATE FROM THE DARWIN 3 PHASE 2 LONG-TERM EXTENSION WITH A MAXIMUM OF 8.2 YEARS OF EXPOSURE
Annals of the Rheumatic Diseases·2023· 2 citedOpen Access
POS0307 A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS
Annals of the Rheumatic Diseases·2023· 2 citedOpen Access
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
New England Journal of Medicine·2023· 112 cited
Tracking Early Atherosclerosis by Audiometry; A Review of Studies in a High Risk Population
Medical Research Archives·2023Open Access
Using Audiometry to Track Atherosclerosis
SSRN Electronic Journal·2023Open Access
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
The Journal of Rheumatology·2021· 41 citedOpen Access
Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis
EMJ Rheumatology·2020· 1 citedOpen Access
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
The Lancet·2019· 208 cited
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extension
Arthritis Research & Therapy·2019· 49 citedOpen Access
The Impact of Time Since First Diagnosis on the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis
Queensland's institutional digital repository (The University of Queensland)·2019· 1 cited
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
Rheumatology and Therapy·2019· 15 citedOpen Access
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
The Lancet·2018· 349 citedOpen Access
AB0247 Lack of ageing with long term methotrexate: objective measurements of cognition, audiometry, and sleep
Annals of the Rheumatic Diseases·2018· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Mark C. Genovese(11), Stanley Cohen(8), Alan Kivitz(7), Paul Emery(6), Philip J. Mease(6), Edit Drescher(5), Stuart L. Silverman(5), Désirée van der Heijde(4), Frédéric Vanhoutte(4), Chantal Tasset(4), Pille Harrison(4), Mykola Stanislavchuk(4), Pierre‐Yves Berclaz(4), Roy Fleischmann(4), Christine E. Codding(3), Maxime Dougados(3), Ying‐Chou Chen(3), Inmaculada de la Torre(3), Terence Rooney(3), Stephanie de Bono(3)